Attendees must be registered for Elevate-Derm Fall Conference in order to attend this program.
Thursday, November 13, 2025
6:15 PM – 6:30 PM ET Registration & Dinner
6:30 PM – 7:30 PM ET CE Symposium
JW Marriott Tampa Water Street
510 Water Street
Tampa, Florida 33602
Meeting Location: Tampa Bay 5
PROGRAM FEATURES
- Interactive case-based presentation
- Downloadable whiteboard animation
- Online personalized quality-improvement poster-generation portal
PRESENTING FACULTY
 |
Linda Stein Gold, MD Director of Dermatology Clinical Research Henry Ford Health System Detroit, Michigan |
 |
Laura Bush, DMSc, PA-C, DFAAPA Physician Assistant Fayette Area Dermatology Fayetteville, Georgia |
PROGRAM OVERVIEW
This educational symposium is designed to equip healthcare professionals with the skills and knowledge necessary to optimize the management of patients with psoriasis (PsO). Attendees will learn to implement comprehensive assessment tools to evaluate disease severity and determine eligibility for systemic therapy accurately. The symposium will also explore current guideline recommendations alongside efficacy and safety data to support evidence-based selection among a broad and evolving array of treatment options, including emerging oral therapies. Additionally, attendees will be guided in designing individualized treatment plans through effective shared decision-making strategies that align with patient preferences and clinical goals.
TARGET AUDIENCE
This educational activity is specifically designed for dermatology NPs and PAs, and dermatologists involved in the management of patients with plaque psoriasis.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Implement comprehensive assessment tools in practice to determine disease severity and systemic therapy eligibility of patients with PsO
- Analyze guideline recommendations and efficacy and safety data supporting the numerous options within the evolving PsO treatment landscape, including emerging oral options
- Design individualized PsO treatment plans utilizing shared decision-making
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour and 1.0 contact hour in the area of pharmacology.
AAPA CREDIT DESIGNATION STATEMENT – LIVE
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.
This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
